Figure 2.
Non-relapse mortality (NRM), relapse/progression, progression-free survival (PFS) and overall survival (OS). Cumulative incidence of NRM (A) and relapse/progression (B). Kaplan Meier estimates of PFS (C) and OS (D) CsA denotes cyclosporine A, MPA mycophenolic acid, and PT-Cy posttransplant cyclophosphamide.